跳至主要内容
临床试验/NCT04905745
NCT04905745
招募中
不适用

The Effectiveness and Safety of Integrative Korean Medicine Treatment for Bell's Palsy : A Prospective Observational Preliminary Study

Jaseng Medical Foundation1 个研究点 分布在 1 个国家目标入组 100 人2021年5月25日

概览

阶段
不适用
干预措施
Korean integrative medicine
疾病 / 适应症
Facial Paralysis, Peripheral
发起方
Jaseng Medical Foundation
入组人数
100
试验地点
1
主要终点
Facial disability index
状态
招募中
最后更新
2个月前

概览

简要总结

This is an observational study that evaluate the effectiveness and safety of Korean integrative treatments in patients with peripheral facial nerve palsy. Adulthood patients aged between 19 to 69 who were diagnosed with peripheral facial nerve palsy and receive Korean integrative treatments for facial palsy will be enrolled in the study and the change will be followed according to the Facial disability index (FDI) at the 3 month moment after baseline.

详细描述

This is an observational study that evaluate the effectiveness and safety of Korean integrative treatments in patients with peripheral facial nerve palsy. A total of 100 patients who are in age of from 19 to 69, diagnosed with peripheral facial nerve palsy, in acute to subacute stage, and who receive Korean integrative treatments for facial palsy will be enrolled in this study. This study is an observational study and the intervention will be decided not by researchers, but by physicians in the real clinical practice. The treatment will be entirely determined according to each subject's medical conditions by an experienced clinician who has received more than 6 years of education and more than 3 years of training. This study will only record the contents of the intervention. Among all the data generated during the study period, data deemed necessary can be collected in the case record forms. The intervention will also be determined by the clinician, and the researcher presented assessment and data collection timepoints, which is independent of the treatment schedule. The on-treatment visit schedule will be once a week during the treatment is ongoing, and follow-up visit schedule will be on the 5th, 14th, and 53rd weeks after the baseline.

注册库
clinicaltrials.gov
开始日期
2021年5月25日
结束日期
2027年8月31日
最后更新
2个月前
研究类型
Observational
性别
All

研究者

责任方
Principal Investigator
主要研究者

In-Hyuk Ha, KMD

Director of Jaseng Spine and Joint Research Institute

Jaseng Medical Foundation

入排标准

入选标准

  • age of 19 to 69
  • diagnosed with unilateral peripheral facial nerve palsy
  • onset of facial palsy within 3 weeks or less.
  • an individual who can provide written consent form to participate in the study.

排除标准

  • diagnosed with central nervous system disease causing facial palsy
  • secondary facial palsy after multiple sclerosis, tumor, cerebrovascular disease and temporal bone fracture.
  • Ramsay-Hunt syndrome
  • bilateral or recurrent facial nerve palsy.
  • an individual who received any treatment that can have a significant effect on changes in facial paralysis within recent 2 month. (ie. facial nerve decompression surgery)
  • already or planned to be pregnant or breast-feeding within the study period.
  • uncontrolled diabetes mellitus within the last 3 months.
  • within a month after participating any other facial palsy-related clinical trials, or planning to participate other clinical trials within 6 month.
  • impossible to read and understand the documents, regarding informed consent form and the questionnaires.
  • difficult to participate according to the judgement of researchers.

研究组 & 干预措施

Facial palsy

Adulthood facial palsy patients group who receive Korean integrative medicine.

干预措施: Korean integrative medicine

结局指标

主要结局

Facial disability index

时间窗: week 14

This is a questionnaire made to evaluate the subjective sensations of patients on the ability to use facial muscles and their emotional state. It is composed of 10 items, and 1-5 is composed of 5 points per item for movement state, and 6-10 is composed of 6 points per item for sociological state and emotional state.

次要结局

  • Facial nerve grading system (FNGS 2.0)(week 1, 5, 14, 53)
  • Short Form-12 Health Survey (SF-12)(week 1, 5, 14, 53)
  • Patient Global Impression of Change (PGIC)(week 5, 14, 53)
  • Facial disability index (FDI)(week 1, 5, 14, 53)
  • Synkinesis Assessment Questionnaire (SAQ)(week 1, 5, 14, 53)
  • House-Brackmann facial palsy grade system (HB grade)(week 1, 5, 14, 53 and every week during treatment (for survival analysis in complete recovery))
  • Numeric rating scale (NRS)(week 1, 5, 14, 53 and every week during treatment)

研究点 (1)

Loading locations...

相似试验